服務熱(rè)綫:
產(chǎn)品中(zhōng)心

產品簡介
天津(jīn)益(yì)元利康科技有(yǒu)限公(gōng)司是Niomech授權(quán)代理(lǐ)Niomech- IIT GmbH是(shì)一(yī)家德國(guó)的專注於研發(fā)與生(shēng)產環(huán)磷酰(xiān)胺和(hé)異(yì)環磷(lín)酰(xiān)胺化合(hé)物的公(gōng)司。產品包括環(huán)磷酰胺(àn),異環磷(lín)酰(xiān)胺以(yǐ)及(jí)他們的(dí)衍生物(wù),Niomech- IIT GmbH還(huán)提供環(huán)磷酰胺(àn)和異(yì)環磷酰(xiān)胺(àn)合成(chéng)服(fú)務。該公司生產(chǎn)的化合(hé)物用於藥代動力學研究(jiū),體(tǐ)外化學敏(mǐn)感(gǎn)性測(cè)試(shì)和體內測(cè)試,參(cān)考物質等。它們(mén)包括(kuò)代(dài)謝物,降解(jiě)和(hé)水解化(huà)合物,以及生(shēng)產副(fù)產物(wù)。
產(chǎn)品(pǐn)分(fēn)類
Niomech- IIT GmbH是一家德國的(dí)專(zhuān)注(zhù)於研發與生產環(huán)磷(lín)酰(xiān)胺和(hé)異環磷酰胺(àn)化(huà)合(hé)物(wù)的公司。產品(pǐn)包(bāo)括(kuò)環磷酰胺,異環(huán)磷(lín)酰(xiān)胺(àn)以(yǐ)及他們的(dí)衍生物,Niomech- IIT GmbH還(huán)提供(gōng)環(huán)磷(lín)酰胺和異(yì)環磷(lín)酰胺(àn)合成(chéng)服(fú)務。該公司(sī)生產(chǎn)的化(huà)合物用(yòng)於(yú)藥代動力學研究(jiū),體外(wài)化(huà)學敏感(gǎn)性測(cè)試(shì)和體內測(cè)試(shì),參(cān)考物(wù)質(zhì)等。它們包括(kuò)代謝物,降解和(hé)水(shuǐ)解(jiě)化(huà)合物(wù),以及生產(chǎn)副(fù)產物(wù)。
Niomech- IIT GmbH研發(fā)與生產(chǎn)的(dí)化合物(wù)用於(yú)多個領(lǐng)域(yù)的(dí)研究(jiū),如藥(yào)代動(dòng)力(lì)學,體(tǐ)外(wài)化學(xué)敏感性測試(shì),體內測試,參考(kǎo)物質等(děng)。
Niomech- IIT GmbH主營產(chǎn)品:Niomech授權(quán)代(dài)理
1.環(huán)磷酰(xiān)胺,異(yì)環磷酰(xiān)胺化(huà)合物;
2.環(huán)磷(lín)酰胺(àn)或(huò)異環磷(lín)酰(xiān)胺(àn)代謝產物;
3.環(huán)磷(lín)酰胺或(huò)異環(huán)磷酰(xiān)胺(àn)水(shuǐ)解化合物;
4.環(huán)磷(lín)酰(xiān)胺或(huò)異環磷(lín)酰胺生產的副產品(pǐn)。
部(bù)分產品列(liè)表:Niomech授權代理(lǐ)
貨(huò)號 | 產品(pǐn)名(míng)稱(chēng) | cas | 分子(zǐ)重量(liáng) |
D-17272 | mafosfamide cyclohexylamine | 84210-80-0 | 500.45g/mol |
D-17929 | mafosfamide L-lysine | 98845-64-8 | 547.46g/mol |
D-17930 | mafosfamide L-lysine in sterile vials | 98845-64-8 | 547.46g/mol |
D-18844 | 3-dechloroethylifosfamide | 36761-83-8 | 198.59g/mol |
D-18845 | 4-ketocyclophosphamide | 27046-19-1 | 275.07g/mol |
D-18846 | cyclophosphamide mustard | 10159-53-2 | 221.02g/mol |
D-18847 | ifosfamide mustard | 31645-39-3 | 221.02g/mol |
D-18849 | carboxyphosphamide | 22788-18-7 | 293.09g/mol |
D-18851 | 4-hydroperoxyifosfamide | 39800-28-7 | 293.09g/mol |
D-18857 | carboxyifosfamide | 2084059-52-7 | 392.26g/mol |
D-18864 | 4-hydroperoxycyclophosphamide | 39800-16-3 | 293.09g/mol |
D-18866 | 4-ketoifosfamide | 42436-20-4 | 275.07g/mol |
D-18867 | 2-dechloroethylifosfamide | 53459-55-5 | 198.59g/mol |
D-18868 | di(dechloro)cyclophosphamide | 53859-37-3 | 192.20g/mol |
D-18870 | di(dechloro)-4-hydroperoxycyclophosphamide | 76353-74-7 | 224.20g/mol |
D-19575 | glufosfamide | 132682-98-5 | 383.16g/mol |
D-20015 | N-3-chlorpropyl-di(de-N-2-chloroethyl)-cyclophosphamide | 2079937-63-4 | 212.62g/mol |
D-69943 | aldofosfamide-O-pentafluorobenzyloxim | 162377-53-9, | 472.21g/mol |
D-69944 | aldofosfamide-O-pentafluorobenzyloxim-D4 | 2079944-23-1 | 476.21g/mol |
D-17272 | mafosfamide cyclohexylamine | 84210-80-0 | 500.45g/mol |
D-17929 | mafosfamide L-lysine | 98845-64-8 | 547.46g/mol |
D-17930 | mafosfamide L-lysine in sterile vials | 98845-64-8 | 547.46g/mol |
D-18844 | 3-dechloroethylifosfamide | 36761-83-8 | 198.59g/mol |
D-18845 | 4-ketocyclophosphamide | 27046-19-1 | 275.07g/mol |
D-18846 | cyclophosphamide mustard | 10159-53-2 | 221.02g/mol |
D-18847 | ifosfamide mustard | 31645-39-3 | 221.02g/mol |
D-18849 | carboxyphosphamide | 22788-18-7 | 293.09g/mol |
D-18851 | 4-hydroperoxyifosfamide | 39800-28-7 | 293.09g/mol |
D-18857 | carboxyifosfamide | 2084059-52-7 | 392.26g/mol |
D-18864 | 4-hydroperoxycyclophosphamide | 39800-16-3 | 293.09g/mol |
D-18866 | 4-ketoifosfamide | 42436-20-4 | 275.07g/mol |
D-18867 | 2-dechloroethylifosfamide | 53459-55-5 | 198.59g/mol |
D-18868 | di(dechloro)cyclophosphamide | 53859-37-3 | 192.20g/mol |
D-18870 | di(dechloro)-4-hydroperoxycyclophosphamide | 76353-74-7 | 224.20g/mol |
D-19575 | glufosfamide | 132682-98-5 | 383.16g/mol |
D-20015 | N-3-chlorpropyl-di(de-N-2-chloroethyl)-cyclophosphamide | 2079937-63-4 | 212.62g/mol |
D-69943 | aldofosfamide-O-pentafluorobenzyloxim | 162377-53-9, | 472.21g/mol |
D-69944 | aldofosfamide-O-pentafluorobenzyloxim-D4 | 2079944-23-1 | 476.21g/mol |
掃碼加微信